{
    "clinical_study": {
        "@rank": "117676", 
        "arm_group": [
            {
                "arm_group_label": "dHACM", 
                "arm_group_type": "Experimental", 
                "description": "Standard of Care Therapy plus dHACM injection at initial visit, to be repeated if symptoms persist at the time of week 4 and week 8 follow up visits."
            }, 
            {
                "arm_group_label": "Saline Injection", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Standard of Care Therapy plus normal saline injection instead of active agent at initial visit, to be repeated if symptoms persist at the time of week 4 and week 8 follow up visits."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether micronized dehydrated human amniotic\n      membrane (dHACM) suspension is more effective in reducing inflammation than conservative\n      measures alone when used to treat acute/early lateral epicondylitis."
        }, 
        "brief_title": "Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis", 
        "condition": "Epicondylitis, Lateral Humeral", 
        "condition_browse": {
            "mesh_term": [
                "Dehydration", 
                "Tennis Elbow"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years old.\n\n          -  Medicare patients may be selected.\n\n          -  Both male and female patients will be selected.\n\n          -  A negative x-ray of the elbow\n\n          -  Diagnosis of lateral epicondylitis by history and exam with symptoms for no longer\n             than one year.\n\n          -  Females of childbearing potential must be willing to use acceptable methods of\n             contraception (birth control pills, barriers, or abstinence).\n\n          -  Patient understands and is willing to participate in the clinical study and can\n             comply with weekly visits and the follow-up regimen.\n\n          -  Patient has read and signed the IRB/IEC approved Informed Consent Form before\n             screening procedures are undertaken.\n\n        Exclusion Criteria:\n\n          -  Prior surgery at the site\n\n          -  Site exhibits clinical signs and symptoms of infection.\n\n          -  History of chronic soft tissue inflammation of more than 6 months.\n\n          -  A positive X-ray for fracture or significant anatomic abnormality including fracture,\n             advanced arthritis, excessive calcification, etc.\n\n          -  No history of corticosteroid injection within the past 30 days.\n\n          -  Joint instability\n\n          -  No rheumatologic conditions involving the elbow.\n\n          -  No evidence of significant neurological entrapment or neurological disease of the\n             forearm\n\n          -  Concurrent cervical radiculopathy\n\n          -  The presence of comorbidities that can be confused with or can exacerbate the\n             condition including:\n\n               -  Previous elbow trauma\n\n               -  Previous elbow surgery\n\n          -  Patients with a history of more than two weeks treatment with immuno-suppressants\n             (including systemic corticosteroids), cytotoxic chemotherapy within one month prior\n             to initial screening, or who receive such medications during the screening period, or\n             who are anticipated to require such medications during the course of the study. (i.e.\n             a one month \"washout period\" for these drugs.)\n\n          -  Patients on any investigational drug(s) or therapeutic device(s) within 30 days\n             preceding screening.\n\n          -  History of radiation at the site.\n\n          -  Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV.\n\n          -  Patients who are unable to understand the aims and objectives of the trial.\n\n          -  Presence of any condition(s) which seriously compromises the subject's ability to\n             complete this study, or has a known history of poor adherence with medical treatment.\n\n          -  Pregnant or breast feeding.  No pregnancy within the past 6 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01921569", 
            "org_study_id": "AFLATEP001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "dHACM", 
                    "Saline Injection"
                ], 
                "description": "Rest, ice, compression, elevation (RICE), NSAID or salicylate medication for pain, Physical Therapy and stretching exercises, Reduction in impact activities, to include an arm sling.", 
                "intervention_name": "Standard of Care Therapy", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "dHACM", 
                "description": "Injection into affected area with micronized dHACM suspended with total volume of 1 cc normal saline.", 
                "intervention_name": "dHACM Injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Saline Injection", 
                "description": "Injection into affected area with 1.0 cc normal saline solution instead of active agent.", 
                "intervention_name": "Normal Saline Injection", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sharonville", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45241"
                }, 
                "name": "Beacon Orthopaedics & Sports Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Micronized Dehydrated Human Amniotic Membrane (dHACM) Suspension in the Treatment of Lateral Epicondylitis.", 
        "other_outcome": {
            "measure": "Pain scores", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "overall_official": {
            "affiliation": "Beacon Orthopaedics & Sports Medicine", 
            "last_name": "Timothy Kremchek, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients achieving improvement in ASES elbow score in the dHACM treatment group vs the control group.", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01921569"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Proportion of patients achieving improvement in range of motion in the dHACM treatment group vs the control group.", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "MiMedx Group, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "MiMedx Group, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}